ArticleAngewandte Chemie (International ed. in English)2026
Beyond para- and meta-Substitution: Synthesis and Biological Validation of Chalcogen-Rich Thiabicyclo[3.1.1]heptanes as Bioisosteres of Aryl Thioether Derivatives.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
While bicyclo[3.1.1]heptanes (BCHeps) and oxa-/aza-BCHeps have emerged as valuable arene bioisosteres, the corresponding thia-analogs remain underdeveloped. Notably, synthetic efforts to access aryl thioether mimetics have focused predominantly on strain-release thiofunctionalization of [1.1.1]propellane or [3.1.1]propellane to access para- and meta-substituted surrogates, whereas three-dimensional analogs of ortho- and 1,2,4-trisubstituted aryl thioethers remain elusive. Herein, we report a one-pot stepwise protocol featuring anti-thio(seleno)sulfonylation/annulation of bicyclo[1.1.0]butanes (BCBs) to enable scalable access to functionalized 2-thiabicyclo[3.1.1]heptanes (thia-BCHeps) under mild conditions. The synthetic utility is further demonstrated by diverse derivatization of these thia-BCHeps building blocks and facile access to bioisosteres of ortho-, meta-, and 1,2,4-trisubstituted aryl thioether derivatives (e.g., aryl sulfones and aryl sulfoximines). DFT calculations revealed that the reaction proceeded via a polar addition pathway, involving nucleophilic attack of cesium methanesulfinate with BCB. The observed diastereoselectivity originates from the stabilization of the anti-addition transition state by a favorable π-π stacking interaction between two phenyl rings. Crystallographic analysis revealed that these thia-BCHeps display geometric properties almost identical to those of ortho-, meta-, and 1,2,4-trisubstituted aryl thioethers. Physicochemical studies and biological evaluation further validated these thia-BCHeps as a new generation of saturated bioisosteres for aryl thioethers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.